$550 is for catalog # FC-420-1004, which is a "mid output" 300 cycle kit. So up to 8 million reads. High output kits for 300 cycles and all 25M reads costs $1500 (FC-420-1003), also not counting sample prep. Costly little fella for OpEx.
Unconfigured Ad
Collapse
X
-
Looks to me like this is going to be more expensive per base than the MiSeq. Plus the error rate in the BaseSpace examples seems higher than the MiSeq. Very disappointing.Originally posted by misterc View Post$550 is for catalog # FC-420-1004, which is a "mid output" 300 cycle kit. So up to 8 million reads. High output kits for 300 cycles and all 25M reads costs $1500 (FC-420-1003), also not counting sample prep. Costly little fella for OpEx.
Comment
-
-
300 cycles and 16M reads (Illumina spec) for a MiSeq v2 kit is $1000. So, you're getting more MiniSeq reads but for a price increase that ends up keeping the cost per base about... yeah, the same. (~2E-5 cents per base if my napkin math is right)
And what JBKri said about error rates-- comparing to one of my last MiSeq runs, the error rates are about double. Is that typical for the 2-dye chemistry?
Comment
-
-
Okay, so basically no cost-per-read advantage over the MiSeq either. I don't mind paying an extra $50 per run to double my read lengths. But if I were buying a new machine, that wouldn't be worth the extra $100k down payment plus the maintenance, so there's a place for it.
Comment
-
-
Double or more is typical in my tests of NextSeq, for example. But, the optics are different as well as the dye, so it's hard to say whether the 2-dye system causes it.Originally posted by Jessica_L View PostAnd what JBKri said about error rates-- comparing to one of my last MiSeq runs, the error rates are about double. Is that typical for the 2-dye chemistry?
Comment
-
-
2-channel imaging will always struggle to keep the intensities straight amongst the 3 lit bases in 2 images. Everything gets dimmer and less pure in signal as you go from cycle to cycle. This likely is what will drive higher error rates, as I doubt the SBS chemistry is to blame.
Comment
-
-
There is a cost / read advantage if you are doing 2 x 150 PE sequencing. 50% of the capital cost of the MiSeq and the NextSeq-esque wash system also means less maintenance than the MiSeq.Originally posted by jwfoley View PostOkay, so basically no cost-per-read advantage over the MiSeq either.
Overally though, looks like it is targeted to researchers seeking to trade off the lower up front cost for slightly higher run costs and reduced capacity.Last edited by Ingeneious; 01-26-2016, 02:43 PM.
Comment
-
-
Info from Illumina:
The MiniSeq is similar to the technology utilised with our NextSeq platform based on 2-channel SBS chemistry.
Pricing Information
MiniSeq System (SY-420-1001): £35,653
MiniSeq Basic Plan (20004132): £3,350 for 1 additional year’s cover
MiniSeq Comprehensive Plan (20004133): £4,021 for 1 additional year’s cover
So upfront and service costs are half a MiSeq.Code:High Output Kit 2 x 150 (300bp) 7.5 25 FC-420-1003 1,046 High Output Kit 2 x 75 (150 bp) 3.75 25 FC-420-1002 652 High Output Kit 1 x 75 (75 bp) 1.875 25 FC-420-1001 558 Mid Output Kit 2 x 150 (300 bp) 2.4 8 FC-420-1004 384
Output for counting experiments is the same as MiSeq v3 chemistry (25 M reads)
The only thing it lacks are long paired reads 2x300 bp (but those kits are failing at the moment anyway...) and with NexteraXT many of our fragments are shorter than 300 bp anyway...
I think knowing what I know now...I'd probably buy one...specs are only going to improve.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
-
by GATTACATLove this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
-
Channel: Articles
07-01-2026, 11:43 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 10:26 AM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
Today, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
24 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
16 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
33 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
Comment